BOLT

Bolt Biotherapeutics, Inc.

BOLT · CIK 1641281 · Annual (10-K) · Last 4 years

Financial Trends

Revenue$8M
20212024
Net Income−$63M
20212024
Operating CF−$61M
20212024
Free Cash Flow−$61M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.0B$0.0B$0.0B$0.0B
Cost of Revenue————
Gross Profit————
R&D Expense$0.1B$0.1B$0.1B$0.1B
SG&A Expense————
Operating Income$-0.1B$-0.1B$-0.1B$-0.1B
Net Income$-0.1B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-1.65$-1.83$-2.36—
EPS (Diluted)$-1.65$-1.83$-2.36—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.1B$0.2B$0.2B$0.3B
Current Assets$0.1B$0.1B$0.2B$0.2B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.1B$0.1B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.2B$0.3B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.1B$-0.1B$-0.1B$-0.1B
Investing Cash Flow$0.1B$0.1B$0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.3B
← Companies